Filing Details

Accession Number:
0001093557-21-000011
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-25 20:21:24
Reporting Period:
2021-01-22
Accepted Time:
2021-01-25 20:21:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1093557 Dexcom Inc DXCM Surgical & Medical Instruments & Apparatus (3841) 330857544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1466545 Richard Doubleday 6340 Sequence Drive
San Diego CA 92121
Evp Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-01-22 366 $367.51 9,617 No 4 S Indirect by Trust
Common Stock Disposition 2021-01-22 169 $368.20 9,448 No 4 S Indirect by Trust
Common Stock Disposition 2021-01-22 254 $369.31 9,194 No 4 S Indirect by Trust
Common Stock Disposition 2021-01-22 310 $370.24 8,884 No 4 S Indirect by Trust
Common Stock Disposition 2021-01-22 11 $371.98 8,873 No 4 S Indirect by Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect by Trust
No 4 S Indirect by Trust
No 4 S Indirect by Trust
No 4 S Indirect by Trust
No 4 S Indirect by Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 21,524 Direct
Footnotes
  1. On June 15, 2020, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan.
  2. This transaction was executed in multiple trades at prices ranging from $366.87 to $367.66. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  3. Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.
  4. This transaction was executed in multiple trades at prices ranging from $367.90 to $368.49. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  5. This transaction was executed in multiple trades at prices ranging from $369.16 to $369.82. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  6. This transaction was executed in multiple trades at prices ranging from $370.240 to $370.595. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  7. This transaction was executed in multiple trades at prices ranging from $371.675 to $372.015. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.